Global Renal Disease Market Growth (Status and Outlook) 2023-2029

Global Renal Disease Market Growth (Status and Outlook) 2023-2029

Renal disease also known as kidney diseases that affects the functioning of kidneys. According to National Kidney Foundation, Inc., 10% of world’s population is suffering from chronic kidney diseases.

LPI (LP Information)' newest research report, the “Renal Disease Industry Forecast” looks at past sales and reviews total world Renal Disease sales in 2022, providing a comprehensive analysis by region and market sector of projected Renal Disease sales for 2023 through 2029. With Renal Disease sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Renal Disease industry.

This Insight Report provides a comprehensive analysis of the global Renal Disease landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Renal Disease portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Renal Disease market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Renal Disease and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Renal Disease.

The global Renal Disease market size is projected to grow from US$ 95170 million in 2022 to US$ 122870 million in 2029; it is expected to grow at a CAGR of 3.7% from 2023 to 2029.

Considering the global scenario of the market, North America is believed to be the largest market for global renal disease. Moreover the European market is the second largest market for global renal disease and Western Europe region is the dominating the market in Europe. On the other hand, Asia-Pacific (APAC) is expected to grow at significant rate in the global renal disease market during the forecast period. Middle East and Africa (ME&A) is likely to have a limited growth in the market due to less awareness of disease and treatment.

This report presents a comprehensive overview, market shares, and growth opportunities of Renal Disease market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Acute Kidney Problems
Chronic Kidney Diseases
Others

Segmentation by application
Hospital
Clinic
Research Center
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott (US)
Amgen Inc. (US)
Baxter (US)
Bristol-Myers Squibb Company (US)
Keryx Biopharmaceuticals(US)
NephroGenex(US)
Novartis AG (Switzerland)
Pfizer Inc.(US)
Sanofi (France)
Shire Pharmaceuticals Limited (Republic of Ireland)

Please note: The report will take approximately 2 business days to prepare and deliver.